BioHorizons, Inc., a majority-owned subsidiary of Henry Schein, Inc. (NASDAQ:HSIC), is a leading dental implant and biologics company located in Birmingham, Alabama. The company has a broad product offering, including dental implants, surgical planning software and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world. For more information, visit biohorizons.com.
Company’s Keywords:
biotechnology, life sciences, dental implants, biologics, dental implant prosthetics, dental instruments, treatment planning software, laserlok microchannels
450
medical devices
210000000
Sendgrid, Outlook, Emma, ASP.NET, Bootstrap Framework, Multilingual, Microsoft-IIS, reCAPTCHA, Google Analytics, Vimeo, YouTube, AddThis, Mobile Friendly, Facebook Login (Connect), Facebook Widget
1994